

2021 SUMMIT
Oct 25-27, 2021
Nashville, TN
AN ACTION-ORIENTED SUMMIT ON THE DATA AND DIGITAL INFRASTRUCTURE PRECISION MEDICINE NEEDS TO THRIVE
Stakeholders across the healthcare system face significant barriers to the effective implementation of precision medicine.
Solutions must carefully consider the practical realities of a complex, multi-stakeholder environment.
This Summit provides influential leaders a candid, collaborative forum to define and implement solutions that connect the genetic health information network.

An intimate meeting of influential leaders from across in the Genetic Health Information Network
Representing all stakeholders in this ecosystem, including
- Health plans
- Clinicians
- Hospital systems
- Researchers
- Policy makers
- Patients & Advocates
- Laboratories
- IT Vendors
- Pharma
2019 Organizing Committee
PRISCILLA ALFARO, MD
Chief Medical Officer
Zelis
DAWN BARRY
Co-Founder & President
LunaDNA
Kristine Bordenave, MD
Corporate Medical Director
Humana
Carlos Bustamante, PhD
Venture Partner
F-Prime Capital
JOSHUA DENNY, MD
Professor of Biomedical Informatics and Medicine
Vanderbilt University
Henry Garlich
Director, Healthcare Value Solutions & Enhanced Clinical Programs
Blue Shield of California
Trent Haywood, MD, JD
SVP & Chief Medical Officer
Blue Cross Blue Shield Association
Gillian Hooker, PhD, ScM, LCGC
VP, Clinical Development
Concert Genetics
JIM JIRJIS, MD
Chief Health Information Officer
HCA Healthcare
HOWARD LEVY, MD, PHD
Associate Professor of Medicine
Johns Hopkins Medicine
LAURIE MCGRAW
SVP, Health Solutions
American Medical Association
NICK NACLERIO
Founding Partner
Illumina Ventures
ROBERT NUSSBAUM, MD
Chief Medical Officer
Invitae
BRYCE OLSON
Global Marketing Director, Health & Life Sciences
Intel Corp.
JULIE RAMAGE
National Accounts Director, Diagnostics
Pfizer
SHUVAYU SEN, PHD
Executive Director, Center for Observational & Real-World Evidence
Merck
BENJAMIN SOLOMON, MD
Managing Director
GeneDx
The only multi-stakeholder gathering focused on solving the data, digital infrastructure, and economic challenges facing precision medicine
Intimate, carefully curated, invitation-only gathering
Full spectrum of stakeholders
Focused on needs and solutions
Collaborative, discussion-oriented format
Chatham-house rules — non-attribution
No sponsored talks, sales pitches or marketing lists
Published conference summary and recommendations
Identify and resolve practical barriers facing precision medicine by
- Improving the capture of clinical effectiveness and economic value data
- Simplifying the test ordering and resulting workflow for clinicians, hospitals and labs
- Streamlining the genetic test billing, adjudication and payment process
- Reducing the frequency of misordered tests and surprise bills for patients
- Empowering patients to harness the insights in their genetic makeup for greater health

Jim Jirjis, MD
Chief Health Information Officer
HCA Healthcare

Esteban López, MD
Chief Medical Officer, Clinical Strategy Innovation
Health Care Service Corporation
BCBS of IL, MT, NM, OK & TX

Kate Donigan, PhD
Deputy Director, Personalized Medicine & Molecular Genetics (acting)
U.S. Food and Drug Administration (FDA)

Shuvayu Sen, PhD
Executive Director,
Center for Observational & Real-World Evidence
MERCK

Vincent Nelson, MD
VP, Medical Affairs
Blue Cross Blue Shield Association

Mira Irons, MD
Chief Health & Sciences Officer
American Medical Association (AMA)

Margaret Anderson
Managing Director
Deloitte Consulting

Priscilla Alfaro, MD
Chief Medical Officer
Zelis

Kenneth Mandl, MD, MPH
Professor & Director, Computational Health Informatics Program (CHIP)
Harvard Medical School & Boston Children’s Hospital

Stephanie Devaney, PhD
Deputy Director,
All of Us
National Institutes of Health (NIH)

Steven Goldberg, MD
VP, Medical Affairs, Population Health &
Chief Health Officer
Quest Diagnostics

Trish Brown, MS, CGC
Director, Americas Payer Partner & Field Market Access Lead
Illumina

Kate Black
Shareholder, Data, Privacy & Cybersecurity Group
Greenberg Traurig

Victor Wu, MD, MPH
Chief Medical Officer
TennCare

James Lu, MD, PhD
Co-founder & SVP,
Applied Genomics
Helix

Jessica Zeaske
Partner
Echo Health Ventures

Hunt Willard, PhD
Director & Principal
Geisinger National

Lisa Alderson
Co-founder & CEO
Genome Medical

Stephen Knight, MD
President & Managing Partner
F-Prime Capital

Nick Naclerio, PhD
Founding Partner
Illumina Ventures

James Hazel, PhD, JD
Research Fellow, Center for Genetic Privacy and Identity in Community Settings (GetPreCiSe)
Vanderbilt University Medical Center

Terry Jo Bichell, PhD
Rare Disease Biomarkers & Outcomes Measurement Consultant
+78 Net Promoter Score
This Summit is back by popular demand thanks to the enthusiastic response of last year’s participants.